Bioequivalence Study of 6-Mercaptopurine Under Fasting Conditions
NCT00602134
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class
Conditions
Acute Lymphoblastic Leukemia
Interventions
DRUG:
6-Mercaptopurine
Sponsor
Roxane Laboratories